Shanghai Junshi Biosciences' (SHA:688180, HKG:1877) Chairman and Controlling Shareholder Xiong Jun has acquired an additional 100,000 China-listed shares in the firm for 3.8 million yuan as of Tuesday, according to a same-day Hong Kong bourse filing.
The shares, acquired through the centralized bidding platform of the Shanghai bourse, represent 0.01% of the company's share capital.
Xiong Jun intends to continue to increase his shareholding in the healthcare company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.